Lab
Norton - Kings Daughters Health INC
Norton - Kings Daughters Health INC was paid $664K by Medicaid between Jan 2018 and Nov 2024, across 58 billing codes. Its largest line is 80050, General health panel — 14% of everything it billed.
33Billing provider infoNORTON - KINGS DAUGHTERS HEALTH INC
MADISON, IN 47250
MADISON, IN 47250
33aNPI1497024426assigned 12/20/2011
33bProvider typeClinical Medical Laboratory
28Total paid$664K
24GClaims50,283
24DCodes billed58
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Indiana
Rank by total paid#16 of 66
Median peer was paid$53K
This provider vs. median13×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,140 | $14K | |
| 2019 | 5,603 | $79K | |
| 2020 | 7,868 | $92K | |
| 2021 | 9,475 | $143K | |
| 2022 | 9,775 | $132K | |
| 2023 | 8,367 | $129K | |
| 2024incomplete | 5,055 | $75K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80050 | General health panel | 14% | 1,909 | 1,652 | $90K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 11% | 1,398 | 1,203 | $70K |
| 80053 | Comprehensive metabolic panel | 7.4% | 5,831 | 4,943 | $49K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 7.2% | 1,787 | 1,601 | $47K |
| 80061 | Lipid panel | 6.3% | 3,870 | 3,425 | $42K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 5.9% | 1,507 | 1,286 | $39K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 5.9% | 1,508 | 1,287 | $39K |
| 84443 | Thyroid stimulating hormone (TSH) | 5.6% | 2,817 | 2,508 | $37K |
| 83036 | Hemoglobin; glycosylated (A1C) | 5.0% | 4,275 | 3,799 | $33K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 3.7% | 908 | 789 | $25K |
| 85027 | 3.1% | 4,146 | 3,528 | $21K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.8% | 3,052 | 2,504 | $19K |
46 more codes
| 84439 | 2.3% | 2,131 | $16K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 2.3% | 780 | $16K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 2.1% | 2,430 | $14K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.7% | 278 | $12K |
| 88142 | 1.7% | 873 | $11K | |
| 82607 | 1.7% | 893 | $11K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.4% | 1,438 | $9K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.3% | 119 | $9K |
| 82728 | 1.1% | 578 | $7K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,855 | $5K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 186 | $5K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 243 | $5K |
| 87631 | <1% | 35 | $4K | |
| 86803 | <1% | 275 | $3K | |
| 82746 | <1% | 225 | $3K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 113 | $3K |
| 87420 | <1% | 195 | $2K | |
| 83540 | <1% | 412 | $2K | |
| 83735 | <1% | 281 | $2K | |
| 83550 | <1% | 252 | $2K | |
| 87340 | <1% | 189 | $1K | |
| 81003 | <1% | 810 | $1K | |
| 84550 | <1% | 309 | $1K | |
| 86140 | <1% | 194 | $971.00 | |
| 86850 | <1% | 153 | $942.32 | |
| 81001 | <1% | 331 | $850.72 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 64 | $849.64 |
| 85652 | <1% | 304 | $788.34 | |
| 87186 | <1% | 87 | $736.06 | |
| 87077 | <1% | 83 | $655.53 | |
| 82248 | <1% | 119 | $534.43 | |
| 86592 | <1% | 134 | $460.39 | |
| 84481 | <1% | 26 | $440.44 | |
| 87081 | <1% | 83 | $435.72 | |
| 85610 | <1% | 95 | $390.44 | |
| 86038 | <1% | 27 | $326.43 | |
| 82570 | <1% | 69 | $300.37 | |
| 86901 | <1% | 135 | $236.96 | |
| 82950 | <1% | 40 | $168.39 | |
| 86762 | <1% | 15 | $158.29 | |
| 86431 | <1% | 25 | $136.08 | |
| 83615 | <1% | 21 | $100.03 | |
| 82043 | <1% | 12 | $69.36 | |
| 36416 | <1% | 19 | $59.40 | |
| 86900 | <1% | 137 | $16.05 | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 0% | 202 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDOZIER, CAROL (CEO)
Parent organizationNORTON - KINGS DAUGHTERS HEALTH INC
| Provider | Location | Paid |
|---|---|---|
| Lifestream Behavioral Center INC | Leesburg, FL | $16.10M |
| Norton - Kings Daughters Health, INC | Madison, IN | $8.93M |
| Norton - Kings Daughters Health INC | Madison, IN | $1.32M |
| Lifestream Behavioral Center INC | Leesburg, FL | $1K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.